6-K ·Filed Oct 1, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for upcoming clinical catalysts (HLP003 Phase 3 data, HLP004 Phase 2 data) which are the primary value drivers. The name change itself is non-material.
Latest settled — T+5d ⚠ clustered
HELP ▼ -9.99% at T+5d
NEUTRAL call -9.99% · α vs SPY -11.29% · entry $11.91 → $10.72
Latest observation: T+16 -30.14% FF3 residual α
T+1d
-1.76%
call -1.76% · α -2.50%
$11.70
settled 25d ago
T+5d
-9.99%
call -9.99% · α -11.29%
$10.72
settled 19d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Helus Pharma (formerly Cybin Inc.) completed its legal name change to Helus Pharma Inc., effective October 1, 2026, following shareholder approval on September 22, 2026. The ticker symbol HELP remains unchanged. This is a purely administrative rebranding event with no financial impact.
Key Facts
- Legal name changed from Cybin Inc. to Helus Pharma Inc. effective October 1, 2026.
- Shareholders approved the name change at the annual and special meeting on September 22, 2026.
- Ticker symbol HELP remains unchanged on Nasdaq and Cboe Canada.
- New CUSIP: 423492107; new ISIN: CA4234921076.
- No action required from existing shareholders; share certificates remain valid.
Financial Impact
No financial impact — administrative name change only.
Risk Factors
- No new risks introduced by this filing.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001833141-26-000084 |
| Document: heluspharmainc-form6xk10x0.htm | 0001833141-26-000084 |
| Document: 0001833141-26-000084-index-headers.html | 0001833141-26-000084 |
| Document: 0001833141-26-000084-index.html | 0001833141-26-000084 |
| Document: 0001833141-26-000084.txt | 0001833141-26-000084 |
37 reports for HELP
50% Hit rate @ T+20 Went positive at some point 2 of 4 best @ T+20▲ +45.91%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $10.66 | awaiting T+20 | — | $10.52 (−1.27%) |
Oct 26, 2026 1d ago | 3 | $10.11 | awaiting T+20 | — | $10.52 (+4.06%) |
Oct 26, 2026 1d ago | 3 | $10.86 | awaiting T+20 | — | $10.52 (−3.09%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.52 (+0.19%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.52 (+0.19%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.52 (+0.19%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.52 (+0.19%) |
Oct 21, 2026 6d ago | 6-K | $10.50 | awaiting T+20 | — | $10.52 (+0.19%) |
Oct 15, 2026 12d ago | 6-K | $11.05 | awaiting T+20 | — | $10.52 (−4.80%) |
Oct 15, 2026 12d ago | Press Release | $11.05 | awaiting T+20 | — | $10.52 (−4.80%) |
Showing 10 of 37
US Market Status
Market Closed — Opens Wed (16h 44m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers